Skip to main content

Security report for agcbio.com

AGC Biologics · Healthcare · United States

Partial score · DNS & email only

71/100

0–100, higher is better. How it is calculated

AGC Biologics operates as a global contract development and manufacturing organization (CDMO) specializing in biologics and cell & gene therapies. Their website presents a professional and comprehensive overview of their services, including protein expression biologics, pDNA, mRNA, viral vectors, and genetically engineered cells. The company targets biopharmaceutical and biotech firms seeking outsourced manufacturing solutions. Technically, the website is built on HubSpot CMS, integrates Google Analytics and Tag Manager, and uses modern web technologies such as Font Awesome and Flickity sliders. The site is mobile optimized and exhibits good SEO and accessibility basics. Security posture is solid with HTTPS enforced and cookie consent mechanisms in place, though some security headers and explicit incident response information are absent. The WHOIS data is missing or not publicly available, which raises some concerns about domain registration transparency, but the website's professional presentation and compliance with privacy regulations mitigate this risk. Overall, the site scores well on content quality, technical implementation, and privacy compliance, with room for improvement in security best practices and business contact transparency.

Scanned

NIS2 and GDPR posture

GDPR outside view
73/ 100 · Medium
Checks completed
6of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

2 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

Need hands-on remediation? Email guard@offseq.com

Keep watching agcbio.com

This scan found 18 issues across 5 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

Security headers
45
Email security
55
DNS health
80
Network security
100
GDPR outside view
73
Average
71

Not counted

  • SSL/TLS: did not complete in this scan.
  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

AGC Biologics holds a strong position in the healthcare sector as a large-scale CDMO with multiple global facilities. Their business model focuses on providing contract development and manufacturing services for advanced biologics and cell & gene therapies. The company leverages a global footprint with locations in the US, Europe, and Asia, catering to a specialized market segment of biotech and pharmaceutical companies. Their website content and structure indicate a mature digital presence with case studies and leadership information enhancing credibility. The absence of explicit contact emails and phone numbers on the homepage suggests a preference for controlled lead generation via contact forms. The integration of HubSpot tools supports marketing automation and analytics. No direct partnerships or subsidiaries were identified from the website content.

Security posture

The website demonstrates a good security baseline with HTTPS enforced and a cookie consent banner indicating GDPR compliance. However, the lack of visible security headers such as Content-Security-Policy, X-Frame-Options, and others suggests room for improvement. No security policy or incident response contact information is published, which is a gap in transparency and readiness communication. No vulnerabilities or exposed sensitive data were detected in the HTML content. The missing WHOIS data is a concern for domain legitimacy but may be due to privacy protection services. Overall, the security posture is adequate for a commercial website but could be enhanced by publishing security policies, incident response procedures, and implementing additional HTTP security headers.

Recommendations

  1. Implement and publish a detailed security policy and incident response plan on the website.
  2. Add HTTP security headers such as Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security.
  3. Provide explicit contact information for security incidents (e.g., security@ or abuse@ email addresses).
  4. Consider publishing a vulnerability disclosure policy and security.txt file to improve transparency.
  5. Enhance accessibility features to meet higher standards and improve user experience for all visitors.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
AGC Biologics
Description
A global contract development manufacturing organization (CDMO/CMO) offering development & manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV) and genetically engineered cells.
Key services
protein expression biologics development, pDNA manufacturing, mRNA manufacturing, viral vector manufacturing (AAV, LVV, RVV), genetically engineered cell manufacturing
Content quality
good
Branding
consistent

Technology

Stack
HubSpot CMS, Google Analytics, Google Tag Manager, Font Awesome, Flickity slider
Platforms
HubSpot
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
80/100
Good practices seen
  • HTTPS enforced
  • Cookie consent banner implemented
  • Privacy policy present

Analytics and tracking

Services
Google Analytics, HubSpot Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
HubSpot Analytics
Marketing tools
HubSpot
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and professional design.
  2. No WAF or blocking mechanisms detected.
  3. WHOIS data missing or domain not found in public WHOIS, which is unusual.
  4. Privacy and cookie policies are present and GDPR compliant.
  5. No explicit security policy or incident response info found.
  6. No contact emails or phone numbers explicitly found in the provided HTML snippet.
  7. Uses HubSpot CMS and integrates Google Analytics and Tag Manager.
  8. No suspicious or malicious content detected.
  9. Content is healthcare and biotech focused, safe for general audiences.
Technical notes

Notes

The website is built on the HubSpot CMS platform, utilizing modern front-end libraries such as Font Awesome for icons and Flickity for sliders. Google Analytics and Google Tag Manager are integrated for analytics and marketing tracking. The site uses responsive design techniques and includes meta tags for SEO and social media sharing (Open Graph and Twitter cards). Performance appears moderate with some asynchronous CSS loading and optimized images. Accessibility is basic but could be improved. No major technical debt or deprecated technologies were detected. The absence of server security headers in the provided data suggests potential for technical hardening. Hosting provider details were not identified from the HTML content.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Earlier scans of this domain

  1. 59/100Medium16 findings · partial scanView report
Reviews of this site

Share your experience with agcbio.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review agcbio.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.